PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2005 June; 6(2): E231–E236.
Published online 2005 October 6. doi:  10.1208/pt060233
PMCID: PMC2750536

Controlled release of drug via methylcellulose-carboxyvinylpolymer interpolymer complex solid dispersion

Abstract

The purpose of this research was to examine the controlled release of phenacetin (PHE) from solid dispersion by the formation of an interpolymer complex between methyl-cellulose (MC) and carboxyvinylpolymer (CP). The PHE/ polymer composition ratio was fixed at 20[ratio]80 (w/w) in the solid dispersion. The effect of the MC/CP ratio and molecular weight of MC on the PHE release was studied. The release of PHE from the solid-dispersion granules depended on the MC/CP ratio, with a ratio of 50[ratio]50 giving the lowest rate of release. In aqueous solution, this MC/CP ratio resulted in the lowest transmittance, suggesting a maximal extent of interpolymer complex formation between MC and CP. Furthermore, at a MC/CP ratio of 50[ratio]50, the release of PHE from the solid dispersion granules decreased as the molecular weight of the MC increased, reaching a plateau at molecular weights ≥180,000. The contributions of diffusion and polymer relaxation to PHE release increased as the molecular weight of the MC increased. This study shows that it is feasible to control the release of PHE from MC-CP solid dispersion granules by modulating complex formation between MC and CP, which can be accomplished by altering the MC/CP ratio and the molecular weight of MC.

KeyWords: controlled release, solid dispersion, polymer complex, methylcellulose, carboxyvinylpolymer

Full Text

The Full Text of this article is available as a PDF (583K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Sekiguchi K, Obi N. Studies on absorption of eutectic mixture. I. A comparison of the behavior of eutectic mixture of sulfathiazole and that of ordinary sulfathiazole in man. Chem Pharm Bull. 1961;9:866–872.
2. Chiou WL, Riegelman S. Oral absorption of griseofulvin in dogs. Increased absorption via solid dispersion in polyethylene glycol 6000. J Pharm Sci. 1970;59:937–942. doi: 10.1002/jps.2600590703. [PubMed] [Cross Ref]
3. Sugimoto I, Kuchiki A, Nakagawa H, et al. Dissolution and absorption of nifedipine from nifedipine-polyvinylpyrrolidone coprecipitate. Drug Dev Ind Pharm. 1980;6:137–160. doi: 10.3109/03639048009051934. [Cross Ref]
4. Takeuchi H, Handa T, Kawashima Y. Spherical solid dispersion containing amorphous tolbutamide embedded in enteric coating polymers or colloidal silica prepared by spray-drying technique. Chem Pharm Bull. 1987;35:3800–3806. [PubMed]
5. Suzuki H, Sunada H. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem Pharm Bull. 1998;46:482–487. [PubMed]
6. Fujii M, Terai H, Mori T, Sawada Y, Matsumoto M. The properties of solid dispersions of indomethacin, ketoprofen and flurbiprofen in phosphatidylcholine. Chem Pharm Bull. 1988;36:2186–2192. [PubMed]
7. Hirasawa N, Okamoto H, Danjo K. Lactose as a low molecular weight carrier of solid dispersion for carbamazepine and ethenzamide. Chem Pharm Bull. 1999;47:417–420. [PubMed]
8. Nakamichi K, Yasuura H, Fukui H, et al. Preparation of nifedipine-hydroxypropylmethylcellulose phthalate solid dispersion by twin screw extruder and its evaluation. J Pharm Sci Tech Jpn. 1996;56:15–22.
9. Yuasa H, Ozeki T, Kanaya Y, Oishi K, Oyake T. Application of the solid dispersion method to the controlled release of medicine. I. Controlled release of water soluble medicine by using solid dispersion. Chem Pharm Bull. 1991;39:465–467.
10. Yuasa H, Ozeki T, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled released of medicine. II. Sustained release tablet using solid dispersion granule and the medicine release mechanism. Chem Pharm Bull. 1992;40:1592–1696.
11. Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine. V. Suppression mechanism of the medicine release rate in the three-component solid dispersion system. Chem Pharm Bull. 1994;42:337–343.
12. Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dispersion method to the controlled release of medicine. VII. Release mechanism of a highly water-soluble medicine from solid dispersion with different molecular weight of polymer. Chem Pharm Bull. 1995;43:660–665.
13. Ozeki T, Yuasa H, Kanaya Y, Oishi K. Application of the solid dipersion method to the controlled release of medicine. VIII. Medicine release and viscosity of the hydrogel of a water-soluble polymer in a three-component solid dispersion system. Chem Pharm Bull. 1995;43:1574–1579.
14. Yuasa H, Takahashi H, Ozeki T, Kanaya Y, Ueno M. Application of the solid dispersion method to the controlled release of medicine. III. Control of the release rate of slightly water soluble medicine from solid dispersion granules. Chem Pharm Bull. 1993;41:397–399. [PubMed]
15. Yuasa H, Ozeki T, Takahashi H, Kanaya Y, Ueno M. Application of the solid dispersion method to the controlled release of medicine. VI. Release mechanism of slighty water soluble medicine and interaction between flurbiprofen and hydroxypropyl cellulose in solid dispersion. Chem Pharm Bull. 1994;42:354–358.
16. Ozeki T, Yuasa H, Kanaya Y. Application of the solid dispersion method to the controlled release of medicine. IX. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxyprocellulose and interaction between medicine and polymers. Int J Pharm. 1997;11:209–217. doi: 10.1016/S0378-5173(97)00167-1. [Cross Ref]
17. Ozeki T, Yuasa H, Kanaya Y. Control of medicine release from solid dispersion through poly(ethylene oxide)-carboxyvinylpolymer interaction. Int J Pharm. 1998;165:239–244. doi: 10.1016/S0378-5173(98)00011-8. [Cross Ref]
18. Ozeki T, Yuasa H, Kanaya Y. Mechanism of medicine release from solid dispersion composed of poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex and pH effect on medicine release. Int J Pharm. 1998;171:123–132. doi: 10.1016/S0378-5173(98)00159-8. [Cross Ref]
19. Ozeki T, Yuasa H, Kanaya Y. Control of medicine release from solid dispersion composed of poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly(ethylene oxide) J Control Release. 1999;58:87–95. doi: 10.1016/S0168-3659(98)00145-X. [PubMed] [Cross Ref]
20. Ozeki T, Yuasa H, Kanaya Y. Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol® interpolymer complex by with various cross-linking degrees of Carbopol® J Control Release. 2000;63:287–295. doi: 10.1016/S0168-3659(99)00202-3. [PubMed] [Cross Ref]
21. Osada Y, Sato M. Thermal equilibrium of the intermacromolecular complexes of polycarboxylic acids realized by cooperative hydrogen bonding. J Polym Sci. Polym Lett Ed. 1976;14:129–134. doi: 10.1002/pol.1976.130140302. [Cross Ref]
22. Osada Y. Equilibrium study of polymer-polymer complexation of poly(methacrylic acid) and poly(acrylic acid) with complementary polymers through cooperative hydrogen bonding. J Polym Sci, Polym Chem Ed. 1979;17:3485–3498. doi: 10.1002/pol.1979.170171107. [Cross Ref]
23. Ikawa T, Abe K, Honda K, Tsuchida E. Interpolymer complex between poly(ethylene oxide) and poly(carboxylic acid) J Polym Sci. Polym Chem Ed. 1975;13:1505–1514. doi: 10.1002/pol.1975.170130703. [Cross Ref]
24. Bekturov EA, Bimendina LA. Interpolymer complexes. Adv Polym Sci. 1981;41:99–147.
25. Iliopoulos I, Audebert R. Complexation of acrylic acid copolymers with polybases: Importance of cooperative effects. Macromolecules. 1991;24:2566–2575. doi: 10.1021/ma00009a066. [Cross Ref]
26. Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–111. [PubMed]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists